| Lobbyist Public Search |
|
Records prior to registration year 2005 are not available online.
Contact the Lobbyist Division here for assistance.
|
Search data is collected from registration records and disclosure reports
submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining
lobbying services to register annually, and submit disclosure reports twice a year.
|
| Your comments are welcome:
submit feedback
|
|
| Disclosure reporting details |
|
Back to search detail summary
|
|
:
01/01/2013 - 06/30/2013
|
|
Lobbyist name
|
Mary
Kaysen
|
|
Business name
|
Bristol-Myers Squibb Company
|
|
Address
|
104 Valley Street
|
|
City, state, zip code
|
Beverly Farms, MA 01915
|
|
Country
|
US
|
|
Agent type
|
Both
|
|
Phone
|
978-232-1147
|
|
|
|
|
|
| |
|
|
|
|
| |
|
Operating Expenses
|
| 1/1/2013-6/30/2013 |
|
Advertising expenses
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Photocopies, scans
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Computer equipment, supplies
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Professional dues
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Fax charges
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Internet fees
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Legal fees
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Postage, shipping, delivery
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Office supplies, equipment
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Printing expenses
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Public relations expenses
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Rent
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Office and support staff salaries
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Professional subscriptions
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Taxes
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Telephone, cell phone, handheld
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Utilities (heat, water, electricity)
|
$0.00
|
| 1/1/2013-6/30/2013 |
|
Other operating expenses
|
$0.00
|
| | | Total operating expenses |
$0.00
|
|
| |
|
Activities, Bill Numbers and Titles
|
|
H1 -
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
H3400 -
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
H3401
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
S3
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
S1800
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
CC#
An Act making appropriations for the fiscal year 2014 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements (Neutral);
Chapter 224 the Acts of 2012
An Act Improving The Quality Of Health Care and Reducing Costs Through Increased Transparency, Efficiency and Innovation (Neutral);
H27
An Act Making Uniform the Law Regarding Trade Secrets (Neutral);
H678
An Act Authorizing a Special Commission to Study Cytotoxic Drugs in the Environment (Oppose);
H825
An Act Regulating the Disposal of Prescription Medication (Neutral);
H931
An Act Relative to Mastectomies (Neutral);
H974
An Act Relative to Providing Insurance Coverage for Breast Cancer Screening (Neutral);
H978
An Act Relative to Pre-Authorization of Medical and Health Care Services
(Neutral);
H999
An Act Ensuring Access to Life-Saving Colorectal Cancer and Breast Cancer Screening (Support);
S415
An Act Ensuring Access to Life-Saving Colorectal Cancer and Breast Cancer Screening (Support);
H1052
An Act Relative to Prescription Drugs (Neutral);
H1676
An Act Criminalizing the Possession of Ingredients for Manufactured Drugs (Neutral);
H1715
An Act Relative to Non-Competition Agreements (Oppose);
H1729
An Act Relative to the Prohibition of Non-Competition Agreements
(Oppose);
H1927
An Act Relative to the Substitution of Interchangeable Biosimilars (Neutral);
H1933
An Act Establishing Provisions for the Return of Expired Pharmaceuticals
(Neutral);
H1949
An Act to Allow a Sixty-day Bulk Purchase of Prostate Cancer (Neutral);
H1956
An Act to Establish a Statewide Program to Promote Prevention, Diagnosis and Treatment of Type 2 Diabetes (Neutral);
H1962
An Act Relative to the Substitution of Generic Drugs (Neutral);
H1977
An Act Relative to Drug Disposal by Mail Prescriptions (Neutral);
H1978
An Act Relative to Responsible Prescription Prescribing
(Neutral);
H1988
An Act Relative to Suspending Prescription Drug Coverage from Minimum Creditable Coverage
(Oppose);
H1993
An Act Relative to the Definition of Pharmacy
(Neutral);
H2018
An Act to Define Modest Meals and Refreshments in Prescriber Educational Settings
(Oppose);
H2020, S1050
An Act to Reduce Healthcare Costs by Promoting Non-biased Prescriber Education
(Oppose);
H2033
An Act Relative to Safe Disposal of Prescription Drugs
(Oppose);
H2061
An Act Prohibiting Advertising by Pharmaceutical Companies
(Oppose);
H2065
An Act Relating to the Dispension of Pharmaceuticals with an Aesthetic Purpose by Physicians
(Neutral);
H2077
An Act Relative to the Safe Dispensing of Pain Management Medication
(Neutral);
H2081
An Act Providing for the Establishment and Operation of a Cancer Drug Repository Program
(Neutral);
H2082
An Act Establishing a Statewide Discount Program for Pharmaceuticals
(Neutral);
S1094
An Act Establishing a Statewide Discount Program for Pharmaceuticals
(Neutral);
H2096
An Act Establishing a Special Commission to Study and Recommend Improvements in the Delivery of Prescription Drug Benefits for the Citizens of the Commonwealth
(Oppose);
H2104
An Act to Improve Quality of Life by Expanding Access to Palliative Care
(Neutral);
H2646
An Act to Eliminate the Tax Deduction for Direct to Consumer Pharmaceutical Marketing
(Oppose);
S300
An Act Relative to the Prescription Drug Covergae for Seniors and the Disabled
(Neutral);
S399
An Act Relative to Regulation or Discharge of Pharmaceutical and Personal Care Product Laden Wastewater into Private Drinking Water Wells and Municipal Drinking Water Supplies
(Oppose);
S439
An Act Relative to Patient Medication Adherence
(Support);
S471
An Act Relative to Pancreatic Cancer Screening
(Support);
S477
An Act Relative to Patient Protection
(Support);
S483
An Act Regulating Pharmacy Audits
(Oppose);
S484
An Act Regulating Pharmacists as Health Care Providers
(Neutral);
S493
An Act Relative to Women's Health and Cancer Recovery
(Neutral);
S543
An Act to Ensure the Privacy of Patient Prescription Records
(Oppose);
S569
An Act Relative to Mandatory Prescription Drug Coverage
(Oppose);
S846
An Act Relative to Employee Non-Competition Agreements
(Oppose);
S1029
An Act Relative to Prescription Drug Adverse Event Reporting
(Neutral);
S1051
An Act to Prevent Undue Influence on Prescriber Behavior
(Oppose);
S1052
An Act to Restore Integrity in the Marketing of Pharmaceutical Products and Medical Devices
(Oppose);
S1090
An Act to Ensure Safe Medication Administration
(Neutral);
S1220
An Act Relative to Medicare Part B
(Neutral);
S1334
An Act Updating the Research and Development Tax Credit
(Neutral);
S1360
An Act Relative to Tax Credits for Prescription Drugs
(Neutral);
H3415
An Act Relative to Transportation Finance
(Neutral);
S1770
An Act Relative to Transportation Finance
(Neutral);
H3535
An Act Relative to Transportation Finance
(Neutral);
S1378
An Act Establishing a Health Care Electronic Prescribing Tax Credit
(Oppose);
|
Support
|
No direct business association.
| Bristol-Myers Squibb Company |
$20,712.00
|
| | | | Total amount |
$20,712.00
|
|
|
|
|
|
|
Meals, Travel, and Entertainment Expenses
|
| No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
| |
|
Additional Expenses
|
| No additional expenses were filed for this disclosure reporting period. |
|
| |
|
Campaign Contributions
|
| 05/21/2013 |
Committee to Elect Robert A. DeLeo
|
House - 19th Suffolk
|
$200.00
|
| | | Total contributions |
$200.00
|
|
|
|
|